Pittsburgh, PA, United States of America

Stephen Y Chan

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: University of Pittsburgh, The Brigham and Women's Hospital, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Y Chan. Retrieved from https://idiyas.com/inventor/stephen-y-chan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Stephen Y Chan

Introduction

Stephen Y Chan is an accomplished inventor based in Pittsburgh, PA. He has made significant contributions to the field of pulmonary vascular disease through his innovative research and development of therapeutic solutions. With a total of 4 patents, Chan's work is recognized for its potential impact on treatment methodologies.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Therapeutic Small Molecules for Treatment of Pulmonary Hypertension." This patent focuses on compositions and methods for treating pulmonary vascular disease. The invention provides compositions and methods that involve administering a therapeutically effective amount of a YAP/TAZ inhibiting composition and/or a GLS1 inhibiting composition to a subject.

Career Highlights

Stephen Y Chan has had a notable career, working with prestigious institutions such as the University of Pittsburgh and Brigham and Women's Hospital. His research has been pivotal in advancing the understanding and treatment of pulmonary conditions.

Collaborations

Throughout his career, Chan has collaborated with esteemed colleagues, including Thomas Bertero and Seungchan Kim. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Stephen Y Chan's contributions to the field of pulmonary vascular disease through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…